3740 Total Publications
Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention
Udeh-Momoh, C, Zheng, B, Sandebring-Matton, A, Novak, G, Kivipelto, M, Jönsson, L and Middleton, L
2022; Journal J Prev Alzheimers Dis; vol. 9; no. 1; pp. 21-Dec;
Studying APOE epsilon 4 Allele Dose Effects with a Univariate Morphometry Biomarker
Wang, G, Zhou, WJ, Kong, DP, Qu, ZS, Ba, MW, Hao, JG, Yao, T, Dong, QX, Su, Y, Reiman, EM, Caselli, RJ, Chen, KW, Wang, YL and Alzheimer's Dis Neuroimaging, I
2022; Journal Journal of Alzheimers Disease; vol. 85; no. 3; pp. 1233-1250;
The accuracy and robustness of plasma biomarker models for amyloid PET positivity
Benedet, AL, Brum, WS, Hansson, O, Karikari, TK, Zimmer, ER, Zetterberg, H, Blennow, K and Ashton, NJ
PMCID:8819863
; 2022; Journal Alzheimers Res Ther; vol. 14; no. 1; pp. 26;
Impact of physiological factors on longitudinal structural MRI measures of the brain
Zahid, U, Hedges, EP, Dimitrov, M, Murray, RM, Barker, GJ and Kempton, MJ
PMCID:8924876
; 2022; Journal Psychiatry Res Neuroimaging; vol. 321; pp. 111446;
Screening and enrollment of underrepresented ethnocultural and educational populations in the Alzheimer's Disease Neuroimaging Initiative (ADNI)
Ashford, MT, Raman, R, Miller, G, Donohue, MC, Okonkwo, OC, Mindt, MR, Nosheny, RL, Coker, GA, Petersen, RC, Aisen, PS and Weiner, MW
2022; Journal Alzheimers Dement;
Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's disease
Jiang, J, Wang, M, Alberts, I, Sun, X, Li, T, Rominger, A, Zuo, C, Han, Y, Shi, K and Initiative, F
2022; Journal Eur J Nucl Med Mol Imaging;
Survival Analysis in Cognitively Normal Subjects and in Patients with Mild Cognitive Impairment Using a Proportional Hazards Model with Extreme Gradient Boosting Regression
Khajehpiri, B, Moghaddam, HA, Forouzanfar, M, Lashgari, R, Ramos-Cejudo, J, Osorio, RS, Ardekani, BA and Alzheimer's Dis Neuroimaging, I
2022; Journal Journal of Alzheimers Disease; vol. 85; no. 2; pp. 837-850;
